Showing results (481-490 of 617) with videos related to

Sort By:
Pageof 62
Cancer|December 11, 1999
A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinomaD M Gershenson, M Morris, T W Burke, et al.
Phytopathology|March 14, 2025
Identification of Novel Basil Downy Mildew Resistance Genes Using De Novo Comparative TranscriptomicsKelly S Allen, Gregory A DeIulio, Robert Pyne, et al.
Gynecologic Oncology|February 27, 2007
Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinomaHyun S Shvartsman, Charlotte C Sun, Diane C Bodurka, et al.
Plos One|August 7, 2015
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian CarcinomasErin K Crane, Suet-Yan Kwan, Daisy I Izaguirre, et al.
Nature Computational Science|January 4, 2024
The role of complexity for digital twins of citiesG Caldarelli, E Arcaute, M Barthelemy, et al.
Gynecologic Oncology|February 18, 1999
Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancerR A Burger, P J DiSaia, J A Roberts, et al.
The American Journal of Pathology|August 31, 2010
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomasKwong-Kwok Wong, Yvonne T M Tsang, Michael T Deavers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Her-2/neu overexpression and amplification in uterine papillary serous carcinomaBrian M Slomovitz, Russell R Broaddus, Thomas W Burke, et al.
International Journal of Molecular Sciences|March 19, 2013
PAX2 Expression in Ovarian CancerHuijuan Song, Suet-Yan Kwan, Daisy I Izaguirre, et al.
Gynecologic Oncology|December 4, 2010
Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?Marisa A Vineyard, Molly S Daniels, Diana L Urbauer, et al.
Pageof 62